Current progress in the management of rare diseases and orphan drugs in China.

Gong SW, Jin S

Intractable Rare Dis Res. 2012; 1(2):45-52.

DOI: 10.5582/irdr.2012.v1.2.45

Summary Full Text (PDF)

The characterization and role of leukemia cell-derived dendritic cells in immunotherapy for leukemic diseases.

Yuan CJ, Song GH, Jiang GS

Intractable Rare Dis Res. 2012; 1(2):53-65.

DOI: 10.5582/irdr.2012.v1.2.53

Summary Full Text (PDF)

Primary biliary cirrhosis and liver transplantation.

Akamatsu N, Sugawara Y

Intractable Rare Dis Res. 2012; 1(2):66-80.

DOI: 10.5582/irdr.2012.v1.2.66

Summary Full Text (PDF)

Serum microRNA is a promising biomarker for osteogenesis imperfect.

Wang ZQ, Lu YQ, Zhang XM, Ren XZ, Wang YZ, Li ZL, Xu C, Han JX

Intractable Rare Dis Res. 2012; 1(2):81-85.

DOI: 10.5582/irdr.2012.v1.2.81

Summary Full Text (PDF)

Accessory lobes of the liver: A report of 3 cases and review of the literature.

Wang CL, Cheng L, Zhang ZQ, Xie TT, Ding HY, Deng QH, Yuan ZD

Intractable Rare Dis Res. 2012; 1(2):86-91.

DOI: 10.5582/irdr.2012.v1.2.86

Summary Full Text (PDF)

Asperger's syndrome with unusual cerebral pathology: Case report and literature review.

Liu L, Vo V, Ware M, Xiong Z

Intractable Rare Dis Res. 2012; 1(2):92-94.

DOI: 10.5582/irdr.2012.v1.2.92

Summary Full Text (PDF)

New opportunity for orphan drug development in Japan: Early exploratory clinical trial bases promote drug translation from basic studies to clinical application.

Song PP, Gao JJ, Kokudo N, Tang W

Intractable Rare Dis Res. 2012; 1(2):95-97.

DOI: 10.5582/irdr.2012.v1.2.95

Summary Full Text (PDF)